Bone Marrow Cancer can potentially be treated by specialized drug: Study

In a study presented by researchers at the University of Pennsylvania's Abramson Cancer Center at the 2022 American Society of Hematology (ASH) Annual Meeting, a first-of-its-kind drug known as modakafusp alfa showed early promise in combating multiple myeloma, a kind of bone marrow cancer.

Related Keywords

United States ,American ,Dan Vogl ,Takeda Pharmaceuticals ,American Society Of Hematology ,University Of Pennsylvania Abramson Cancer Center ,American Cancer Society ,Abramson Cancer Center ,Annual Meeting ,Clinical Research Unit ,Penn Medicine ,Perelman School ,Bone ,Arrow ,Dancer ,Han ,Potentially ,The ,Reated ,Y ,Specialized ,Drug ,Study ,News ,Ews India ,